Cancer Care Ontario | Cancer Care Ontario

The objective of the Medical Physics Residency Program is to train medical physicists to perform duties competently, professionally and safely in a...

Regimen

MFOLFOX6+ZOLB

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Nov 2025

Guidelines and Advice

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Status: Current
ID: GL 1-23-A

Jul 2021

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Metis-Depistage-du-cancer-colorectal-print.pdf

Metis-Depistage-cancer-poumon-print.pdf

asciminib

ABIRPRED

AZCTIVOS

Algorithmes de tests réflexifs de biomarqueurs du SNC

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD

MATRIX

Medical Physics Residency Program

MFOLFOX6+ZOLB

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Pages